Registered entities
Entrada Therapeutics, Inc.
Reg. No. 1689375United States
Entrada Therapeutics, Inc.
Reg. No. 81-3983399United States
Entrada Therapeutics, Inc.
Reg. No. 20211538086United States
Innovation
33 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 3,845 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 11 |
| 2023 | 14 |
| 2024 | 20 |
| 2025 | 16 |
| 2026 | 4 |
Social engagement
Social engagement: 35.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Wellington, 5AM Ventures, MRLV, Roche.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 5 | 38% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
5 Jul 2025 · Associate Director, Biosample Operations · Boston
16 Jun 2025 · Administrative & Events Associate · Boston
13 Jun 2025 · Administrative & Events Associate · Boston
12 Jun 2025 · Study Start Up Lead (CONTRACT) · Boston
25 Jan 2025 · Contracts Specialist · Boston
Based on job postings tracked across public sources.
Recent activity
2 Jul 2026
Event
19th International Congress on Neuromuscular Diseases - ICNMD
17 Jun 2026
Event
Parent Project Muscular Dystrophy's 2026 Annual Conference